BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9017007)

  • 1. Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: long-term follow-up.
    Papadimitrakopoulou VA; Hong WK; Lee JS; Martin JW; Lee JJ; Batsakis JG; Lippman SM
    J Natl Cancer Inst; 1997 Feb; 89(3):257-8. PubMed ID: 9017007
    [No Abstract]   [Full Text] [Related]  

  • 2. Biologic modifiers and chemoprevention of cancer of the oral cavity.
    Richtsmeier WJ
    N Engl J Med; 1993 Jan; 328(1):58-9. PubMed ID: 8416272
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis.
    Lippman SM; Batsakis JG; Toth BB; Weber RS; Lee JJ; Martin JW; Hays GL; Goepfert H; Hong WK
    N Engl J Med; 1993 Jan; 328(1):15-20. PubMed ID: 8416267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention in head and neck cancer.
    Mellott A; Vokes E
    Cancer Treat Res; 2001; 106():221-35. PubMed ID: 11225004
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized trial of supplemental beta-carotene to prevent second head and neck cancer.
    Mayne ST; Cartmel B; Baum M; Shor-Posner G; Fallon BG; Briskin K; Bean J; Zheng T; Cooper D; Friedman C; Goodwin WJ
    Cancer Res; 2001 Feb; 61(4):1457-63. PubMed ID: 11245451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 13-cis-retinoic acid, beta-carotene and other anti-oxidant agents in chemoprevention and therapy of head and neck cancer.
    Toma S; Palumbo R; Raffo P; Spadini N; Rosso R
    Eur J Cancer Prev; 1994 Jul; 3(4):374-7. PubMed ID: 7950898
    [No Abstract]   [Full Text] [Related]  

  • 7. Retinoids: application in premalignant lesions and oral cancer.
    Contreras Vidaurre EG; Bagán Sebastián JV; Gavalda C; Torres Cifuentes EF
    Med Oral; 2001; 6(2):114-23. PubMed ID: 11500628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population-based trial of beta-carotene chemoprevention of head and neck cancer.
    Mayne ST; Zheng T; Janerich DT; Goodwin WJ; Fallon BG; Cooper DL; Friedman CD
    Adv Exp Med Biol; 1992; 320():119-27. PubMed ID: 1442276
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemoprevention of squamous cell carcinoma of the head and neck.
    Wrangle JM; Khuri FR
    Curr Opin Oncol; 2007 May; 19(3):180-7. PubMed ID: 17414634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of oral squamous cell carcinomas.
    Scheer M; Kuebler AC; Zöller JE
    Onkologie; 2004 Apr; 27(2):187-93. PubMed ID: 15138354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of retinoids in chemoprevention of oral squamous cell carcinoma: an overview.
    Conley BA; Ord RA
    J Craniomaxillofac Surg; 1996 Dec; 24(6):339-45. PubMed ID: 9032601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis.
    Lippman SM; Benner SE; Hong WK
    Cancer Res; 1994 Apr; 54(7 Suppl):2025s-2028s. PubMed ID: 8137332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemoprevention of oral cancer--clinical and experimental studies].
    Szumiło J; Podlodowska J; Podlodowski W; Starosławska E; Burdan F
    Pol Merkur Lekarski; 2012 Feb; 32(188):138-42. PubMed ID: 22590920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status and prospects of chemoprevention in oral squamous epithelial carcinomas and precancerous lesions].
    Zöller JE; Scheer M
    Mund Kiefer Gesichtschir; 2000 May; 4 Suppl 1():S160-8. PubMed ID: 10938656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micronuclei, a biomarker for chemoprevention trials: results of a randomized study in oral pre-malignancy.
    Benner SE; Lippman SM; Wargovich MJ; Lee JJ; Velasco M; Martin JW; Toth BB; Hong WK
    Int J Cancer; 1994 Nov; 59(4):457-9. PubMed ID: 7960211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isotretinoin for prevention of second primary squamous cell carcinoma of the head and neck.
    Briggs RJ; Forastiere AA
    Otolaryngol Head Neck Surg; 1991 Nov; 105(5):752-4. PubMed ID: 1754264
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemoprevention of aerodigestive epithelial cancers.
    Lippman SM; Hong WK
    Adv Exp Med Biol; 1992; 320():151-61. PubMed ID: 1442280
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression.
    Shin DM; Mao L; Papadimitrakopoulou VM; Clayman G; El-Naggar A; Shin HJ; Lee JJ; Lee JS; Gillenwater A; Myers J; Lippman SM; Hittelman WN; Hong WK
    J Natl Cancer Inst; 2000 Jan; 92(1):69-73. PubMed ID: 10620636
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemoprevention of cancers of the oral cavity and the head and neck.
    Sankaranarayanan R; Mathew B; Nair PP; Somanathan T; Varghese C; Jyothirmayi R; Krishnan Nair M
    IARC Sci Publ; 1996; (136):13-25. PubMed ID: 8791111
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemoprevention of head and neck cancer.
    Glover KY; Papadimitrakopoulou VA
    Curr Oncol Rep; 2003 Mar; 5(2):152-7. PubMed ID: 12583833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.